Combination of nanotechnology with vascular targeting agents for effective cancer therapy
出版年份 2017 全文链接
标题
Combination of nanotechnology with vascular targeting agents for effective cancer therapy
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 4, Pages 2982-2992
出版商
Wiley
发表日期
2017-06-13
DOI
10.1002/jcp.26051
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The herbal medicine Melissa officinalis extract effects on gene expression of p53, Bcl-2, Her2, VEGF-A and hTERT in human lung, breast and prostate cancer cell lines
- (2017) Rana Jahanban-Esfahlan et al. GENE
- Tumor vascular infarction: prospects and challenges
- (2017) Rana Jahanban-Esfahlan et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways
- (2017) Maryam Majidinia et al. JOURNAL OF PINEAL RESEARCH
- Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation
- (2017) Khaled Seidi et al. TUMOR BIOLOGY
- Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor
- (2016) Hua Jin et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application
- (2016) Pei-Xin Lai et al. BIOMATERIALS
- Long non-coding RNAs in cancer drug resistance development
- (2016) Maryam Majidinia et al. DNA REPAIR
- Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy
- (2016) Yuanke Li et al. JOURNAL OF CONTROLLED RELEASE
- NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors
- (2016) Flavio Curnis et al. Nano Research
- Gold Nanoparticle–Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy
- (2016) Wei Li et al. Scientific Reports
- Hesa-A Down-Regulates erb/b2 Oncogene Expression and Improves Outcome of Oral Carcinoma in a Rat Model
- (2015) Mehran Mesgari Abbasi et al. Asian Pacific Journal of Cancer Prevention
- Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 Expression in Vivo
- (2015) Mehran Mesgari Abbasi et al. Asian Pacific Journal of Cancer Prevention
- Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy
- (2015) Manhong Li et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma
- (2015) Jinfang Zhu et al. Journal of Biomedical Nanotechnology
- Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities
- (2014) Mehran Mesgari Abbasi et al. Asian Pacific Journal of Cancer Prevention
- DOX-MTX-NPs Augment p53 mRNA Expression in OSCC Model in Rat: Effects of IV and Oral Routes
- (2014) Mehran Mesgari Abbasi et al. Asian Pacific Journal of Cancer Prevention
- Emodin-Loaded Magnesium Silicate Hollow Nanocarriers for Anti-Angiogenesis Treatment through Inhibiting VEGF
- (2014) Hua Ren et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted Gold Nanoparticles as Vascular Disrupting Agents During Radiation Therapy
- (2014) R.I. Berbeco et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities
- (2014) Yuanyuan Liu et al. Nanoscale
- Anti-Angiogenesis Therapy in the Vx2 Rabbit Cancer Model with a Lipase-cleavable Sn 2 Taxane Phospholipid Prodrug using αvβ3-Targeted Theranostic Nanoparticles
- (2014) Dipanjan Pan et al. Theranostics
- Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales
- (2013) Asmaa E El-Kenawi et al. BRITISH JOURNAL OF PHARMACOLOGY
- The p53 family and VEGF regulation: “It’s complicated”
- (2013) Morvarid Farhang Ghahremani et al. CELL CYCLE
- p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway
- (2013) M Farhang Ghahremani et al. CELL DEATH AND DIFFERENTIATION
- Indole conjugated silica and magnetic nanoparticles as inhibitors of HIF
- (2013) Qiu-Yun Chen et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Preparation of Curcumin-Loaded Poly(ester amine) Nanoparticles for the Treatment of Anti-Angiogenesis
- (2013) Qiuxia Ding et al. Journal of Biomedical Nanotechnology
- RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system
- (2013) Yu Sakurai et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle Delivered Vascular Disrupting Agents (VDAs): Use of TNF-Alpha Conjugated Gold Nanoparticles for Multimodal Cancer Therapy
- (2013) Mithun M. Shenoi et al. MOLECULAR PHARMACEUTICS
- Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
- (2013) Shailendra Giri et al. PLoS One
- Comparison of anti-angiogenic properties of pristine carbon nanoparticles
- (2013) Mateusz Wierzbicki et al. Nanoscale Research Letters
- Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
- (2013) Marta Cesca et al. Frontiers in Oncology
- Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo
- (2012) Keyang Huang et al. ACS Nano
- The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling
- (2012) Dongdong Sun et al. BIOMATERIALS
- Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances
- (2011) Ehud Segal et al. BIOMATERIALS
- Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
- (2011) Angelo Corti et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- VEGFR-2 targeted cellular delivery of doxorubicin by gold nanoparticles for potential antiangiogenic therapy
- (2011) Arijit Das et al. JOURNAL OF NANOPARTICLE RESEARCH
- Gold nanoparticle-aided brachytherapy with vascular dose painting: Estimation of dose enhancement to the tumor endothelial cell nucleus
- (2011) Wilfred Ngwa et al. MEDICAL PHYSICS
- Inhibiting angiogenesis by oral immunisation with poly(ε-caprolactone)–poly(ethylene glycol)–poly(ε-caprolactone) nanoparticle-encapsulated basic fibroblast growth factor
- (2011) JianLin Long et al. Micro & Nano Letters
- Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody
- (2011) Donghua Liu et al. MOLECULAR PHARMACEUTICS
- Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge
- (2011) Rochelle R. Arvizo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature
- (2011) Tingyuan Yang et al. Nanomedicine-Nanotechnology Biology and Medicine
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Shape Effect of Carbon Nanovectors on Angiogenesis
- (2010) Padmaparna Chaudhuri et al. ACS Nano
- Disrupting established tumor blood vessels
- (2010) Mark J. McKeage et al. CANCER
- Mechanisms of resistance to antiangiogenesis therapy
- (2010) Faisal Azam et al. EUROPEAN JOURNAL OF CANCER
- Ternary biomolecular nanoparticles for targeting of cancer cells and anti-angiogenesis
- (2010) Il-Kyu Park et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- HPMA copolymer–cyclic RGD conjugates for tumor targeting☆☆☆
- (2009) Daniel B. Pike et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis
- (2009) Rania Harfouche et al. ANGIOGENESIS
- Antiangiogenic properties of silver nanoparticles
- (2009) Sangiliyandi Gurunathan et al. BIOMATERIALS
- Vascular Endothelial Growth Factor-C siRNA Delivered via Calcium Carbonate Nanoparticle Effectively Inhibits Lymphangiogenesis and Growth of Colorectal Cancer In Vivo
- (2009) Xiao-Wen He et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- MMP-2 alters VEGF expression via αVβ3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells
- (2009) Chandramu Chetty et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic Targeting of αvβ3Integrin and Galectin-1 with Heteromultivalent Paramagnetic Liposomes for Combined MR Imaging and Treatment of Angiogenesis
- (2009) Ewelina Kluza et al. NANO LETTERS
- In vivo therapeutic silencing of hypoxia-inducible factor 1 alpha (HIF-1α) using single-walled carbon nanotubes noncovalently coated with siRNA
- (2009) Geoffrey Bartholomeusz et al. Nano Research
- Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties
- (2009) Melissa M Kemp et al. NANOTECHNOLOGY
- Active targeting schemes for nanoparticle systems in cancer therapeutics
- (2008) James D. Byrne et al. ADVANCED DRUG DELIVERY REVIEWS
- Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-β receptor inhibitor on extravasation of nanoparticles from neovasculature
- (2008) Mitsunobu R. Kano et al. CANCER SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started